Detection of Alpha II-Spectrin Breakdown Products in the Serum of Neonates With Congenital Heart Disease*

Objectives:To determine if alpha II-spectrin breakdown products can be detected in the serum of neonates with congenital heart disease in the perioperative period.Design:Prospective observational cohort study.Setting:Pediatric cardiac ICU in an urban tertiary care academic center.Patients:Neonates w